Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
Abortifacient Agents, Nonsteroidal
/ administration & dosage
Abortifacient Agents, Steroidal
/ administration & dosage
Abortion, Induced
Female
Humans
Lupus Nephritis
/ complications
Mifepristone
/ administration & dosage
Misoprostol
/ administration & dosage
Pregnancy
Pregnancy Trimester, Second
Renal Insufficiency
/ complications
Treatment Outcome
Abortion
lupus nephritis
mifepristone
misoprostol
Journal
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
ISSN: 1473-0782
Titre abrégé: Eur J Contracept Reprod Health Care
Pays: England
ID NLM: 9712127
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
23
2
2021
medline:
26
10
2021
entrez:
22
2
2021
Statut:
ppublish
Résumé
In the second trimester, medical abortion is preferred as it is less invasive, and the surgical method carries more risk. There is a paucity of published literature on medical abortion in women with renal failure requiring haemodialysis. We came across a woman who presented with rapidly progressive renal failure at 18 weeks of gestation and required therapeutic abortion. We are reporting the challenges, outcomes, and precautions to be taken while performing a medical abortion in such a case.
Identifiants
pubmed: 33615941
doi: 10.1080/13625187.2021.1879782
doi:
Substances chimiques
Abortifacient Agents, Nonsteroidal
0
Abortifacient Agents, Steroidal
0
Misoprostol
0E43V0BB57
Mifepristone
320T6RNW1F
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM